• 

  Incidental Detection of Elastofibroma Dorsi With 68Ga-FAPI-46 and 18F-FDG PET/CT in a Patient With Esophageal Cancer

  Gallery

  Incidental Detection of Elastofibroma Dorsi With 68Ga-FAPI-46 and 18F-FDG PET/CT in a Patient With Esophageal Cancer

Incidental Detection of Elastofibroma Dorsi With 68Ga-FAPI-46 and 18F-FDG PET/CT in a Patient With Esophageal Cancer

Artineh Hayrapetian ¹, Mark […]

jsctek_u4g7i52025-10-15T16:40:45+00:001, Feb 2021|Publications|

• 

  Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18 F-Labeled FAP Inhibitor

  Gallery

  Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18 F-Labeled FAP Inhibitor

Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an 18 F-Labeled FAP Inhibitor

Johannes Toms ¹, Jürgen Kogler ¹

jsctek_u4g7i52025-10-13T13:44:26+00:006, Dec 2020|Publications|

• 

  SOFIE announces promotion of Mike Parisi to Vice President of Sales & Marketing

  Gallery

  SOFIE announces promotion of Mike Parisi to Vice President of Sales & Marketing

SOFIE announces promotion of Mike Parisi to Vice President of Sales & Marketing

Mike brings nearly 25 years of Nuclear Medicine, Sales and Management experience to SOFIE. Mike […]

jsctek_u4g7i52025-10-13T13:34:29+00:0024, Nov 2020|News|

• 

  SOFIE Signs Commercial Supply Agreement with Lantheus Holdings, Inc. to Manufacture PyL™

  Gallery

  SOFIE Signs Commercial Supply Agreement with Lantheus Holdings, Inc. to Manufacture PyL™

SOFIE Signs Commercial Supply Agreement with Lantheus Holdings, Inc. to Manufacture PyL™

SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, has signed a […]

jsctek_u4g7i52025-10-15T16:41:29+00:0013, Nov 2020|News|

• 

  Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging

  Gallery

  Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging

Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging

Christian Schmidkonz ¹, Simon Rauber

jsctek_u4g7i52025-10-15T16:39:34+00:005, Nov 2020|Publications|

• 

  SOFIE Biosciences Inc. (SOFIE) concludes $27.4m Series C Financing

  Gallery

  SOFIE Biosciences Inc. (SOFIE) concludes $27.4m Series C Financing

SOFIE Biosciences Inc. (SOFIE) concludes $27.4m Series C Financing

Dulles, VA, November 4, 2020 – SOFIE, whose vision is to improve patient outcomes […]

jsctek_u4g7i52025-10-13T13:44:37+00:004, Nov 2020|News|

• 

  Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers?

  Gallery

  Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers?

Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers?

Patrick Conen ^1 2, Felix M […]

jsctek_u4g7i52025-10-13T13:41:36+00:004, Nov 2020|Publications|

• 

  68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient

  Gallery

  68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient

68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient

Liang Zhao ¹, Jianwei Gu ²

jsctek_u4g7i52025-10-15T16:40:45+00:003, Oct 2020|Publications|

• 

  [ 68 Ga]Ga-DOTA-FAPI-04 and [ 18 F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer

  Gallery

  [ 68 Ga]Ga-DOTA-FAPI-04 and [ 18 F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer

[ 68 Ga]Ga-DOTA-FAPI-04 and [ 18 F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer

Jieling Zheng ¹, Shaobo Yao ²

Article available for purchase […]

jsctek_u4g7i52025-10-15T16:39:30+00:0010, Aug 2020|Publications|

• 

  Comparison of [ 68 Ga]Ga-DOTA-FAPI-04 and [ 18 F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer

  Gallery

  Comparison of [ 68 Ga]Ga-DOTA-FAPI-04 and [ 18 F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer

Comparison of [ 68 Ga]Ga-DOTA-FAPI-04 and [ 18 F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer

Haojun Chen¹, Yizhen Pang¹, 

jsctek_u4g7i52025-10-15T16:39:30+00:0029, Jul 2020|Publications|